{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:01:20Z","timestamp":1784678480748,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53865-x","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:08:16Z","timestamp":1779250096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the compatibility, stability, and antimicrobial effectiveness of vancomycin and cefepime admixtures in peritoneal dialysis solutions"],"prefix":"10.1038","volume":"16","author":[{"given":"Richard W.","family":"Dudley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariann D.","family":"Churchwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie H.","family":"Oestreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Charvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"53865_CR1","unstructured":"United States Renal Data System. 2023 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. U S Ren. Data Syst (2023)."},{"key":"53865_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","volume":"42","author":"PKT Li","year":"2022","unstructured":"Li, P. K. T. et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit. Dial Int. 42, 110\u2013153 (2022).","journal-title":"Perit. Dial Int."},{"key":"53865_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/089686080902900101","volume":"29","author":"F de Vin","year":"2009","unstructured":"de Vin, F., Rutherford, P. & Faict, D. Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use. Perit. Dial Int. 29, 5\u201315 (2009).","journal-title":"Perit. Dial Int."},{"key":"53865_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/08968608231196034","volume":"43","author":"SJ Lewis","year":"2023","unstructured":"Lewis, S. J., Alves, B., Ratnam, S. & Churchwell, M. D. Stability and compatibility of intraperitoneal antimicrobials in peritoneal dialysate solutions. Perit. Dial Int. 43, 431\u2013441 (2023).","journal-title":"Perit. Dial Int."},{"key":"53865_CR5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2215\/CJN.14631218","volume":"14","author":"CC Szeto","year":"2019","unstructured":"Szeto, C. C. & Li, P. K. Peritoneal dialysis-associated peritonitis. Clin. J. Am. Soc. Nephrol. 14, 1100\u20131105 (2019).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"53865_CR6","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.clinthera.2019.08.021","volume":"41","author":"H Kaur","year":"2019","unstructured":"Kaur, H. et al. High pyridine generation in ceftazidime-icodextrin admixtures used to treat peritoneal dialysis-associated peritonitis. Clin. Ther. 41, 2446\u20132451 (2019).","journal-title":"Clin. Ther."},{"key":"53865_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/0896860819887636","volume":"40","author":"TT Nguyen","year":"2020","unstructured":"Nguyen, T. T. et al. Pyridine levels in ceftazidime-peritoneal dialysis admixtures stored at body temperature. Perit. Dial Int. 40, 171\u2013178 (2020).","journal-title":"Perit. Dial Int."},{"issue":"6","key":"53865_CR8","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/ckj\/sfac012","volume":"15","author":"SWY So","year":"2022","unstructured":"So, S. W. Y. et al. Stability and compatibility of antibiotics in peritoneal dialysis solutions. Clin. Kidney J. 15 (6), 1071\u20131078 (2022).","journal-title":"Clin. Kidney J."},{"key":"53865_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/106002809402800503","volume":"28","author":"LM Vaughan","year":"1994","unstructured":"Vaughan, L. M. & Poon, C. Y. Stability of ceftazidime and vancomycin alone and in combination in heparinized and nonheparinized peritoneal dialysis solution. Ann. Pharmacother. 28, 572\u2013576 (1994).","journal-title":"Ann. Pharmacother"},{"key":"53865_CR10","first-page":"137","volume":"49","author":"WM Mawhinney","year":"1992","unstructured":"Mawhinney, W. M., Adair, C. G. & Gorman, S. P. Stability of vancomycin hydrochloride in peritoneal dialysis solution. Am. J. Hosp. Pharm. 49, 137\u2013139 (1992).","journal-title":"Am. J. Hosp. Pharm."},{"key":"53865_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1128\/AAC.21.3.528","volume":"21","author":"DL Sewell","year":"1982","unstructured":"Sewell, D. L. & Golper, T. A. Stability of antimicrobial agents in peritoneal dialysate. Antimicrob. Agents Chemother. 21, 528\u2013529 (1982).","journal-title":"Antimicrob. Agents Chemother."},{"key":"53865_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0272-6386(83)80064-X","volume":"3","author":"DL Sewell","year":"1983","unstructured":"Sewell, D. L. et al. Stability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of insulin and heparin. Am. J. Kidney Dis. 3, 209\u2013212 (1983).","journal-title":"Am. J. Kidney Dis."},{"key":"53865_CR13","first-page":"1604","volume":"47","author":"JM Drake","year":"1990","unstructured":"Drake, J. M., Myre, S. A., Staneck, J. L. & Draeger, R. W. Antimicrobial activity of vancomycin, gentamicin, and tobramycin in peritoneal dialysis solution. Am. J. Hosp. Pharm. 47, 1604\u20131606 (1990).","journal-title":"Am. J. Hosp. Pharm."},{"key":"53865_CR14","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1345\/aph.18336","volume":"33","author":"JC Williamson","year":"1999","unstructured":"Williamson, J. C. et al. Stability of cefepime in peritoneal dialysis solution. Ann. Pharmacother. 33, 906\u2013909 (1999).","journal-title":"Ann. Pharmacother"},{"key":"53865_CR15","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1345\/aph.1G321","volume":"40","author":"AO Nornoo","year":"2006","unstructured":"Nornoo, A. O. & Elwell, R. J. Stability of vancomycin in icodextrin peritoneal dialysis solution. Ann. Pharmacother. 40, 1950\u20131954 (2006).","journal-title":"Ann. Pharmacother"},{"key":"53865_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3747\/pdi.2015.00062","volume":"36","author":"D Ranganathan","year":"2016","unstructured":"Ranganathan, D. et al. Stability of antibiotics for intraperitoneal administration in Extraneal 7.5% icodextrin peritoneal dialysis bags (STAB Study). Perit. Dial Int. 36, 421\u2013426 (2016).","journal-title":"Perit. Dial Int."},{"key":"53865_CR17","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1345\/aph.1E324","volume":"38","author":"RJ Elwell","year":"2004","unstructured":"Elwell, R. J., Volino, L. R. & Frye, R. F. Stability of cefepime in icodextrin peritoneal dialysis solution. Ann. Pharmacother. 38, 2041\u20132044 (2004).","journal-title":"Ann. Pharmacother"},{"key":"53865_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3747\/pdi.2015.00018","volume":"36","author":"G Deslandes","year":"2016","unstructured":"Deslandes, G. et al. Stability and compatibility of antibiotics in peritoneal dialysis solutions applied to automated peritoneal dialysis in the pediatric population. Perit. Dial Int. 36, 676\u2013679 (2016).","journal-title":"Perit. Dial Int."},{"key":"53865_CR19","unstructured":"Cefepime [package insert]. Lake Forest, IL: Hospira, Inc. (2012)."},{"issue":"3","key":"53865_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/bmc.3288","volume":"29","author":"M Dabrowska","year":"2015","unstructured":"Dabrowska, M. et al. A degradation study of cefepime hydrochloride in solutions under various stress conditions by TLC-densitometry. Biomed. Chromatogr. 29 (3), 388\u2013395 (2015).","journal-title":"Biomed. Chromatogr."},{"key":"53865_CR21","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 35th ed. CLSI Supplement M100S. Clin. Lab. Stand. Inst. (2025)."},{"issue":"2","key":"53865_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1310\/hpj5202-132","volume":"52","author":"WD Kufel","year":"2017","unstructured":"Kufel, W. D. et al. Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story? Hosp. Pharm. 52 (2), 132\u2013137 (2017).","journal-title":"Hosp. Pharm."},{"key":"53865_CR23","unstructured":"United States Pharmacopeial Convention. USP 43\u2013NF 38, General Chapter\u2009<\u20091191>: Stability considerations in dispensing practice Vol. 8044 (U.S. Pharmacopeia, 2018)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53865-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53865-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53865-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:16:08Z","timestamp":1784675768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53865-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53865"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53865-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22891"}}